+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Livestock Diagnosis - Global Strategic Business Report

  • PDF Icon

    Report

  • 472 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6089407
The global market for Livestock Diagnosis was valued at US$6.0 Billion in 2025 and is projected to reach US$10.5 Billion by 2032, growing at a CAGR of 8.4% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Livestock Diagnosis Market - Key Trends & Drivers Summarized

Why Is Livestock Diagnosis Central to Modern Veterinary and Agricultural Management?

Livestock diagnosis refers to the detection, monitoring, and management of diseases and physiological conditions in farm animals, including cattle, poultry, swine, sheep, and goats. With livestock health directly impacting food safety, productivity, and economic output, rapid and accurate diagnosis has become a top priority in global animal husbandry. Diagnostic tools help identify infections, reproductive conditions, metabolic disorders, and zoonotic diseases - facilitating early intervention, treatment optimization, and prevention of outbreaks that could devastate herds or enter the human food chain.

As global meat, dairy, and egg production continues to grow, especially in Asia-Pacific, Africa, and Latin America, disease surveillance and herd health monitoring are becoming critical to sustainable livestock farming. Increasing concerns over antimicrobial resistance (AMR), foodborne illnesses, and pandemic risks are further elevating the need for routine diagnostics, especially in densely populated or industrial-scale farms. These factors are positioning livestock diagnostics not merely as a veterinary tool but as an integral component of food security and public health infrastructure.

How Are Diagnostic Technologies Evolving to Support Precision Livestock Farming?

Advancements in point-of-care diagnostics, biosensors, and molecular detection are revolutionizing how livestock diseases are identified and managed. Portable PCR devices, rapid immunoassays, ELISA kits, and microfluidic lab-on-chip systems are enabling on-site diagnosis of viral, bacterial, and parasitic infections in minutes rather than days. These tools are increasingly integrated into mobile veterinary units and farm management systems, allowing for faster decision-making and targeted treatments.

Wearable sensors and precision livestock monitoring platforms are enabling continuous health surveillance based on behavioral, physiological, and biometric data. Combined with AI and machine learning algorithms, these systems detect subtle deviations in feeding, temperature, or movement - serving as early indicators of disease or stress. Remote diagnostics and tele-veterinary services are also gaining traction, particularly in remote or underserved farming regions. These innovations are laying the groundwork for precision livestock health management, where disease control becomes proactive rather than reactive.

What Trends Are Influencing Adoption Across Animal Health Ecosystems?

The intensification of animal farming and increasing biosecurity regulations are driving widespread adoption of livestock diagnostics across both developed and emerging markets. Large-scale dairy and poultry operations are implementing herd-wide diagnostic programs to manage production efficiency and reduce the economic impact of disease. Government initiatives, including animal health surveillance programs, livestock insurance, and disease eradication campaigns, are promoting the use of diagnostic tests at both the individual and population level.

Moreover, rising consumer demand for antibiotic-free and hormone-free animal products is compelling producers to invest in disease detection as a means to minimize prophylactic drug use. The growth of traceability standards and sustainable certifications in meat and dairy supply chains is further encouraging systematic diagnostic testing. As animal health becomes a defining factor in brand differentiation and market access, livestock diagnostics are becoming a strategic priority for both producers and agribusiness companies.

What Is Driving Growth in the Global Livestock Diagnosis Market?

The growth in the livestock diagnosis market is driven by rising concerns over animal disease outbreaks, increasing demand for safe animal-derived products, and the global shift toward precision farming practices. A primary driver is the rising prevalence of transboundary animal diseases - such as avian influenza, foot-and-mouth disease, and African swine fever - which are prompting stricter surveillance and rapid-response diagnostics at the farm and national levels.

Technological progress in molecular biology, biosensors, and real-time data analytics is making diagnostics more accessible, affordable, and deployable across diverse farm settings. Governments and multinational agencies are funding veterinary infrastructure upgrades to improve outbreak preparedness and food safety. Additionally, livestock producers are recognizing that early diagnosis translates into lower treatment costs, reduced losses, and improved reproductive efficiency. These dynamics are fostering a strong growth trajectory for livestock diagnostics as a critical enabler of sustainable and resilient animal agriculture worldwide.

Report Scope

The report analyzes the Livestock Diagnosis market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product (Consumables, Systems, Software, Other Products); Technology (Immunodiagnostics, Molecular Diagnostics, Other Technologies); Animal Type (Ruminants, Swine, Poultry, Other Animal Types); End-Use (Reference Laboratories, Diagnostic Hospitals & Clinics, Point-Of-Care Testing, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Consumables segment, which is expected to reach US$4.9 Billion by 2032 with a CAGR of a 9.6%. The Systems segment is also set to grow at 9.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $1.6 Billion in 2025, and China, forecasted to grow at an impressive 13.0% CAGR to reach $2.4 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Livestock Diagnosis Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Livestock Diagnosis Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Livestock Diagnosis Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abaxis Inc., Advanced Animal Diagnostics, Alfa Wassermann, Antech Diagnostics, AsureQuality Limited and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Livestock Diagnosis market report include:

  • Abaxis Inc.
  • Advanced Animal Diagnostics
  • Alfa Wassermann
  • Antech Diagnostics
  • AsureQuality Limited
  • bioMérieux S.A.
  • Bio-Rad Laboratories Inc.
  • Covetrus Inc.
  • Diagnostics For Animals (D4A)
  • DiaSys Diagnostic Systems GmbH
  • Elanco Animal Health Inc.
  • Eurolyser Diagnostica GmbH
  • Heska Corporation
  • IDEXX Laboratories Inc.
  • Merck Animal Health
  • Neogen Corporation
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Livestock Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Global Demand for Protein-Rich Diets Drives Vaccination in Livestock Production
  • Expansion of Commercial Animal Farming Throws the Spotlight on Preventive Veterinary Care
  • Outbreaks of Zoonotic Diseases Propel Growth in Mass Livestock Immunization Campaigns
  • Government-Led Livestock Immunization Programs Strengthen Market Accessibility in Rural Areas
  • Advancements in Recombinant and Vector-Based Vaccines Enhance Efficacy and Duration
  • Growing Emphasis on Antimicrobial Stewardship Spurs Shift Toward Preventive Vaccination
  • Expansion of Cold Chain Infrastructure Improves Vaccine Distribution in Developing Regions
  • Increased Surveillance and Disease Reporting Accelerates Prophylactic Vaccine Uptake
  • Integration of Digital Herd Health Monitoring Supports Targeted Vaccine Scheduling
  • Emergence of Multivalent and Thermostable Vaccines Simplifies Logistics and Boosts Compliance
  • Genetic Advancements in Animal Breeding Create Demand for Tailored Vaccine Solutions
  • Surging Investment in Animal Health Startups Expands R&D Pipelines in Livestock Immunology
  • Trade Regulations and Animal Export Standards Drive Compulsory Vaccination Protocols
  • Growth in Aquaculture and Poultry Segments Expands Use of Specialized Vaccination Programs
  • Improved Awareness Among Farmers Enhances Vaccination Coverage and Market Penetration
  • Increased Focus on Wildlife and Cross-Species Disease Control Spurs Novel Vaccine Development
  • Private-Public Partnerships Fuel Global Livestock Disease Eradication Strategies
  • Pharma Consolidation and M&A Activity Strengthen Distribution Capabilities of Animal Vaccines
  • Globalization of Livestock Trade Intensifies Demand for Standardized Immunization Solutions
  • Veterinary Training and Extension Services Generate Informed Vaccine Adoption at Farm Level
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Livestock Vaccines Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Livestock Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Bovine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Bovine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Bovine Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Poultry Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Poultry Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Poultry Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Porcine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Porcine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Porcine Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Other Vaccine Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Parenteral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Parenteral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Parenteral Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Other Routes of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Other Routes of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Other Routes of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Oral Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Veterinary Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Veterinary Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Veterinary Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Veterinary Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Veterinary Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Veterinary Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Live Attenuated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Live Attenuated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Live Attenuated Vaccine Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Inactivated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Inactivated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Inactivated Vaccine Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 41: World Recent Past, Current & Future Analysis for Recombinant Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 42: World Historic Review for Recombinant Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: World 13-Year Perspective for Recombinant Vaccine Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 44: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 45: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: World 13-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abaxis Inc.
  • Advanced Animal Diagnostics
  • Alfa Wassermann
  • Antech Diagnostics
  • AsureQuality Limited
  • bioMérieux S.A.
  • Bio-Rad Laboratories Inc.
  • Covetrus Inc.
  • Diagnostics For Animals (D4A)
  • DiaSys Diagnostic Systems GmbH
  • Elanco Animal Health Inc.
  • Eurolyser Diagnostica GmbH
  • Heska Corporation
  • IDEXX Laboratories Inc.
  • Merck Animal Health
  • Neogen Corporation
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

Table Information